Clarity Medical Systems, Inc.

Reopia Optics, Llc.

Conformis, Inc.

Eyedetec Medical, Inc.

Other

Imatx, Inc.

Barry Jonathan Linder

Yan Zhou

Philipp K Lang

Daniel Steines

William L Shea

Konstantinos Tsougarakis

Bhaskar Rao Vissa

Phillip Baker

Rene Vargas-Voracek

David John Miller

Bradford B Chew

Siau-Way Liew

Claude Donald Arnaud

Hacene Bouadi

Willem Crone

Yeou-Yen Cheng

David Miller

Cecily Anne Snyder

Ronald Linder

James Dippo

Robert Sykora

Baker Phil

Spectacles that control myopia progression have a central zone that achieves foveal vision correction and distributed micro-reticle(s) and corresponding micro-lens(es) around the paracentral and/or peripheral zone of the spectacle. Each micro-lens is disposed between its corresponding micro-reticle and the pupil of a wearer's eye. The micro-reticle(s) and micro-len(s) are integrated with the structure of the spectacle to partially block some of the paracentral and/or peripheral objects from surrounding optical environment. The rest of the paracentral and/or peripheral retinal areas are still available for a wearer's eye to sense the presence and movement of surrounding objects.

Anti-myopia-progression spectacles and associated methods

Myopia is a clinically significant and growing problem around the world. A major cause is the increasing time spent indoors by children, for example, playing video games, studying, and watching television. Exposure to sufficient overall light levels is known to be protective, and prevents the onset and also delays the progression of myopia. Embodiments include a computerized myopia progression retarding ('MPR') system that includes a light source configured to provide illumination and an illumination sensor configured to sense ambient light. The MPR system also includes a processor configured to dynamically adjust the illumination in terms of either wavelength bands or luminance provided by the light source to solicit a target wavelength band or luminance for retarding myopia progression of a user.

Systems and methods for retarding myopia progression

A wearable optical device increases a Resolvable Object Distance Range (RODR) thereby reducing focusing demands of a plurality of objects located along a visual angle distance for a user with presbyopia or myopia. The devise includes a negative refractive element and a positive refractive element located along an optical axis. The negative refractive element and the positive refractive element are separated from each other by a separation space and at a separation distance suitable for mounting on a spectacle. A surface of a non-central zone of the negative refractive element or the positive refractive element is a Fresnel surface. The separation space is filled by an intermediate media with a refractive index lower than that of the negative refractive element or the positive refractive element. In one embodiment, the intermediate media is an optical grade resin or polymer. In another embodiment, a spacing seal is located around a periphery of the separation space, and the intermediate media is a low-humidity gas for reducing condensation within the separation space during ambient temperature changes.

Spectacles for presbyopia treatment and myopia progression control and associated methods

Combined headset with mask

Spectacles that control myopia progression have a central zone that achieves foveal vision correction and distributed micro-reticle(s) and corresponding micro-lens(es) around the paracentral and/or peripheral zone of the spectacle. Each micro-lens is disposed between its corresponding micro-reticle and the pupil of a wearer's eye. The micro-reticle(s) and micro-lens(es) are integrated with the structure of the spectacle to partially block some of the paracentral and/or peripheral objects from surrounding optical environment. The rest of the paracentral and/or peripheral retinal areas are still available for a wearer's eye to sense the presence and movement of surrounding objects.

Myopia is a clinically significant and growing problem around the world. A major cause is the increasing time spent indoors by children, for example, playing video games, studying, and watching television. Exposure to outdoor light is known to be protective, and prevents the onset and also delays the progression of myopia. Embodiments of the present invention provide simulated continuous outdoor light in either a closed or open feedback loop sufficient to retard myopia progression.

Presbyopia treatment and anti-myopia spectacles comprise a negative refractive element facing an object and a positive refractive element facing a patient eye. The negative refractive element has a central zone with a strong negative refractive power. The positive refractive element has a central zone with a less strong positive refractive power. The front focal point of the central zone of the positive lens does not have to overlap with the front focal point of the central zone of the negative lens. The negative refractive element and the positive refractive element are axially separated by a relatively small distance such that the combination of the two refractive elements is compact enough to be made into an easily wearable spectacle. For myopia progression control, at least one portion of the paracentral and/or peripheral zone of at least one of the two refractive elements has a relative add power with respect to that of the central zone such that the image of an off-axis distant or intermediate object is formed in front of a corresponding paracentral or peripheral retina area to create myopic defocus on the corresponding retina area.

Spectacles and associated methods for presbyopia treatment and myopia progression control

In order to take advantage of the real time nature of intra-operative refraction or wavefront aberrometry, and visually make the history of the measurements apparent to a surgeon, a histogram of frequency vs IOL results calculated from an IOL formula is computed and IOL suggestions being accumulated are displayed in a histogram. One embodiment is a means to present to a surgeon a histogram of intra-operative refractions. Another embodiment is to automatically and intra-operatively detect the aphakic phase of a cataract surgery to display a histogram of a recommended IOL power.

Obtaining and displaying histogram and/or confidence of intra-operative refraction and/or IOL power recommendation

In one embodiment, a wavefront sensor is combined with a slit lamp eye examination device so that real time aberration values of an eye being examined can be viewed during a slit lamp eye examination session.

Optimizing vision correction procedures

The present invention relates to methods for determining meniscal size and shape for use in designing therapies for the treatment of various joint diseases. The invention uses an image of a joint that is processed for analysis. Analysis can include, for example, generating a thickness map, a cartilage curve, or a point cloud. This information is used to determine the extent of the cartilage defect or damage and to design an appropriate therapy, including, for example, an implant. Adjustments to the designed therapy are made to account for the materials used.

Methods for determining meniscal size and shape and for devising treatment

Modularized eye treatment devices, systems, kits and method are disclosed which include therapy delivery modules that are combined in a housing to deliver one or more therapies to a patient. Therapy modules include temperature control modules, moisture delivery modules and massage delivery modules. A controller can be provided that identifies which therapy modules are provided and therapy is adjusted based on the identification of which modules are provided in the housing.

Growing community of inventors

Danville, CA, United States of America

Barry Jonathan Linder